問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of Ophthalmology

Division of Family Medicine

更新時間:2023-09-19

張義昇Chang, Yi-Sheng
  • Principal Investigator
  • Clinical Trial Experience (year) 22 years 9 個月

篩選

List

3Cases

2023-04-22 - 2026-10-30

Phase III

Active
PHase 3, Multicenter, RandOmized, Double-masked, PlacEbo-CoNtrolled Study of TInlarebant to EXplore Safety and Efficacy in the Treatment of Geographic Atrophy (the PHOENIX Study)
  • Condition/Disease

    Geographic Atrophy

  • Test Drug

    錠劑

Participate Sites
4Sites

Recruiting4Sites

2009-01-01 - 2010-06-30

Phase II

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2015-10-15 - 2018-04-30

Phase III

A Two-Year, Randomized, Double-Masked, Multicenter, Two-Arm Study Comparing the Efficacy and Safety of RTH258 6 mg Versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration
  • Condition/Disease

    Neovascular Age-Related Macular Degeneration

  • Test Drug

    RTH258

Participate Sites
5Sites

Terminated5Sites